Neuromod Devices announced that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire, the first bimodal neuromodulation device of its kind to be approved by the FDA for the treatment of tinnitus.
Neuromod Devices non-invasive device, Lenire, is the first of its kind granted approval to treat tinnitus in the US market. At least 25,000,000 Americans are.
/PRNewswire/ Irish medical device company, Neuromod Devices Ltd., which specialises in the treatment of tinnitus, has reached an agreement with Tinnitus.